Alyeska Investment Group, L.P. Horizon Therapeutics Public LTD CO Transaction History

Alyeska Investment Group, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $194,220 - $354,259	3,113 New	3,113 $354,000
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $6.02 Million - $8.82 Million	75,833 Added 15.28%	572,136 $45.6 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $3.81 Million - $4.85 Million	-44,122 Reduced 8.16%	496,303 $52.2 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $6.44 Million - $7.84 Million	65,368 Added 13.76%	540,425 $58.2 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $34.5 Million - $41.4 Million	375,057 Added 375.06%	475,057 $52 Million
Q3 2020 Nov 16, 2020	SELL	$55.23 - $79.93 $59.4 Million - $86 Million	-1,075,353 Reduced 91.49%	100,000 $7.77 Million
Q1 2020 May 15, 2020	BUY	$24.87 - $38.56 $6.85 Million - $10.6 Million	275,468 Added 30.61%	1,175,353 $34.8 Million
Q4 2019 Feb 14, 2020	SELL	$25.43 - $36.67 $6.75 Million - $9.74 Million	-265,604 Reduced 22.79%	899,885 $32.6 Million
Q3 2019 Nov 14, 2019	SELL	$23.0 - $27.97 $245,847 - $298,971	-10,689 Reduced 0.91%	1,165,489 $31.7 Million
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $26.8 Million - $33.5 Million	1,176,178 New	1,176,178 $0

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.